Jiangsu, China

Medshine Discovery Inc.

Calculating rank
USPTO Granted Patents = 73

% Expired Patents = 5.5



Forward Citations = 63

Loading Chart...
Loading Chart...

190 inventors (with patents filed for the assignee):

goldMedal Shuhui Chen (60 out of 237 patents)

silverMedal Jian Li (34 out of 238 patents)

bronzeMedal Charles Z Ding (15 out of 57 patents)

4.  Guoping Hu (12 out of 37 patents)

5.  Lingyun Wu (11 out of 28 patents)

6.  Yunfu Luo (10 out of 41 patents)

7.  Haiying He (8 out of 62 patents)

8.  Wenyuan Qian (8 out of 23 patents)

9.  Lihong Hu (7 out of 33 patents)

10.  Kevin X Chen (7 out of 32 patents)

11.  Maoyi Lei (7 out of 11 patents)

12.  Shuhui Chen (7 out of 131 patents)

13.  Zhigan Jiang (6 out of 23 patents)

14.  Zhaoguo Chen (6 out of 10 patents)

15.  Yanxin Yu (5 out of 6 patents)


Core Competencies:
Heterocyclic Compounds
KRAS Inhibitors
LSD1 Inhibitors
SGLT1 Inhibitors
RHO Kinase Inhibitors
EGFR Inhibitors
mTORC Inhibitors
ACC Inhibitors
Caspase Inhibitors
PDE4 Inhibitors
CDK4/6 Inhibitors
Immunomodulators

73 patents:

Company Overview
Medshine Discovery Inc., based in Jiangsu, China, specializes in the development of innovative therapeutic solutions focusing on heterocyclic compounds. The company is engaged in cutting-edge research and technology in areas such as KRAS inhibitors, LSD1 inhibitors, and various other targeted therapies including SGLT1, RHO kinase, EGFR, mTORC, and ACC inhibitors. Medshine aims to advance the treatment landscape for various diseases through its commitment to scientific excellence and novel drug discovery.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

73 Patents

#9 in Jiangsu

#449 in China

#10,290 in the World

Jiangsu, CN
Jiangsu, China
Forward Citations = 63

190 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medshine Discovery Inc.. Retrieved from https://idiyas.com/company/medshine-discovery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…